Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 6/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL510774 | 0.95 | DRD3 (0.47) | DRD2DRD4DRD3ALDH1A1KDM4E | |
| SCHEMBL135640 | 0.93 | DNM1 (0.40) | ALDH1A1KDM4EGAAPAOXDNM1 | |
| SCHEMBL16908423 | 0.93 | KDM4E (0.41) | DRD2DRD4DRD3ALDH1A1KDM4E | |
| SCHEMBL3280642 | 0.91 | DNM1 (0.42) | DRD2DRD4DRD3ALDH1A1DNM1 | |
| SCHEMBL292986 | 0.90 | DNM1 (0.45) | DNM1 | |
| SCHEMBL291199 | 0.90 | DNM1 (0.45) | DNM1 | |
| SCHEMBL292050 | 0.89 | ALDH1A1 (0.39) | DRD2DRD4DRD3ALDH1A1KDM4E | |
| SCHEMBL3285678 | 0.88 | EPHX1 (0.46) | DRD2DRD4DRD3DNM1 | |
| SCHEMBL291266 | 0.88 | KDM5A (0.41) | DRD2DRD4DRD3PAOXACHE | |
| SCHEMBL93199 | 0.87 | ALDH1A1 (0.51) | ALDH1A1KDM4EHSD17B10ALOX15GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116023573-A | CO (carbon monoxide) 2 Responsive core-shell structure microsphere and preparation method thereof | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | claimed |
| WO-2011127364-A2 | A COMBINATION OF CROSSLINKED CATIONIC AND AMPHOLYTIC POLYMERS FOR PERSONAL AND HOUSEHOLD APPLICATIONS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2011-10-13 | — | — | WO | claimed |
| US-7700540-B2 | Hard surface cleaning composition | THE CLOROX COMPANY (US) | 2010-04-20 | — | — | US | claimed |
| US-20070099816-A1 | Hard Surface Cleaning Composition | THE CLOROX COMPANY | 2007-05-03 | — | — | US | claimed |
| US-5069754-A | Reinforcement with amphoteric polymer | MITSUI-CYANAMID, LTD. (JP) | 1991-12-03 | — | — | US | claimed |
| US-20240240027-A1 | METHOD FOR PRODUCING MODIFICATION INORGANIC NANOSHEET, AND MODIFICATION INORGANIC NANOSHEET | FUKUOKA INSTITUTE OF TECHNOLOGY (JP) | 2024-07-18 | — | — | US | disclosed |
| US-11981763-B2 | Resin composition for stereolithographic modeling | KURARAY NORITAKE DENTAL INC. (JP) | 2024-05-14 | — | — | US | disclosed |
| EP-4335822-A1 | METHOD FOR MANUFACTURING MODIFIED INORGANIC NANOSHEET, AND MODIFIED INORGANIC NANOSHEET | Fukuoka Institute Of Technology (JP) | 2024-03-13 | — | — | EP | disclosed |
| WO-2023169485-A1 | COPOLYMER, TREATMENT AGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 北京马普新材料有限公司 | 2023-09-14 | — | — | WO | disclosed |
| US-11655324-B2 | Resin composition for optical shaping | KURARAY NORITAKE DENTAL INC. (JP) | 2023-05-23 | — | — | US | disclosed |
| CN-116023573-A | CO (carbon monoxide) 2 Responsive core-shell structure microsphere and preparation method thereof | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | disclosed |
| US-20230091071-A1 | RESIN COMPOSITION FOR STEREOLITHOGRAPHY | KURARAY NORITAKE DENTAL INC. (JP) | 2023-03-23 | — | — | US | disclosed |
| US-5250602-A | Polymer emulsion and method for preparing the same | MITSUI-CYANAMID, LTD. (JP) | 1993-10-05 | — | — | US | disclosed |
| US-5132358-A | POLYMER EMULSION | MITSUI-CYANAMID, LTD. (JP) | 1992-07-21 | — | — | US | disclosed |
| US-5069721-A | HIGH STRENGTH; CATIONIC POLYMER EMULSION | MITSUI-CYANAMID, LTD. (JP) | 1991-12-03 | — | — | US | disclosed |
| US-5069754-A | Reinforcement with amphoteric polymer | MITSUI-CYANAMID, LTD. (JP) | 1991-12-03 | — | — | US | disclosed |
| EP-0392688-A1 | Mortar concrete composition | MITSUI CYANAMID LIMITED (JP) | 1990-10-17 | — | — | EP | disclosed |
| EP-0385627-A1 | Polymer emulsion | MITSUI-CYANAMID, LTD. (JP) | 1990-09-05 | — | — | EP | disclosed |
| EP-0385626-A1 | Papermaking method | MITSUI-CYANAMID, LTD. (JP) | 1990-09-05 | — | — | EP | disclosed |
| US-4719272-A | FOR CATIONIC POLYSACCHARIDE GRAFT POLYMERS | NATIONAL STARCH AND CHEMICAL CORPORATION (US) | 1988-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230091071-A1 | RESIN COMPOSITION FOR STEREOLITHOGRAPHY | MAT2B, ARCN1, COL2A1 | DRD2 407/4885DRD4 1070/4885DRD3 873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.